22437, A NOVEL HUMAN SULFATASE AND USES THEREFOR

Details for Australian Patent Application No. 2002211365 (hide)

Owner MILLENNIUM PHARMACEUTICALS, INC.

Inventors GLUCKSMANN, Maria, Alexandra; RUDOLPH-OWEN, Laura, A.

Pub. Number AU-A-2002211365

PCT Pub. Number WO2002/052019

Priority 60/257,082 21.12.00 US

Filing date 3 October 2001

Wipo publication date 8 July 2002

International Classifications

C12N 015/55 Mutation or genetic engineering - Hydrolases (3)

A61P 017/02 Drugs for dermatological disorders

A61P 025/00 Drugs for disorders of the nervous system

A61P 035/00 Antineoplastic agents

A61P 035/04 Antineoplastic agents

C12N 009/16 Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

G01N 033/573 Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

C12Q 001/34 Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002211365

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002211366

2002211364-HUMAN ANTI-CD40 ANTIBODIES